{"id":22020,"date":"2021-09-14T11:39:04","date_gmt":"2021-09-14T11:39:04","guid":{"rendered":"https:\/\/celonpharma.com\/?p=22020"},"modified":"2021-09-14T11:39:04","modified_gmt":"2021-09-14T11:39:04","slug":"3-posters-to-be-published-at-34th-ecnp-congress","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/","title":{"rendered":"3 posters to be published at 34th ECNP Congress"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The 34th ECNP Congress will take place on October 2-5 in Lisbon. This is the most important European scientific meeting dedicated to brain research for disease. Each year, this event attracts over 5,000 psychiatrists, neurologists and psychologists from around the world.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During the 34th ECNP Congress, posters will be presented. Posters by Sylwia Janowska &#8211; Clinical Development Leader, Miko\u0142aj Mat\u0142oka &#8211; Research Group Leader &#8211; Neuropsychiatric Diseases were honored with the ECNP Excellence Award.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Inflammatory cytokine plasma levels correlation with MADRS score in patients with treatment-resistant major depression after dry-powder inhaled esketamine administration<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><u>M. Matloka<\/u>&nbsp;<sup>1<\/sup>, &nbsp;A. Gajos-Draus<sup>1<\/sup>, I. Majkowska<sup>1<\/sup>, S. Kokhanovska<sup>1<\/sup>, P. Pankiewicz<sup>1<\/sup>, S. Janowska<sup>1<\/sup>, K. W\u00f3jcik<sup>1<\/sup>, M. Wieczorek<sup>1<\/sup>, J. Pieczykolan<sup>1<\/sup>,<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>1<\/sup>R&amp;D Centre, Celon Pharma SA, Marymoncka 15, 05-152 Kazun Nowy, Poland<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Safety assessment of esketamine administered via dry powder inhaler in patients with treatment-resistant major depression<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><u>S. Janowska<sup>1<\/sup><\/u>, M. Wieczorek<sup>1<\/sup>, P. Ga\u0142ecki&nbsp;<sup>2<\/sup>,<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>1<\/sup>Celon Pharma SA, R&amp;D Centre, \u0141omianki, Poland<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>2<\/sup>&nbsp;Department of Adult Psychiatry, Medical University of \u0141\u00f3d\u017a, \u0141\u00f3d\u017a, Poland<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Safety assessment of esketamine administration via dry powder inhaler in patients with treatment-resistant bipolar depression<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><u>M. Wieczorek<sup>1<\/sup><\/u>, S. Janowska<sup>1<\/sup>, P. Ga\u0142ecki<sup>2<\/sup><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>1<\/sup>Celon Pharma SA, R&amp;D Centre, \u0141omianki, Poland<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>2<\/sup>&nbsp;Department of Adult Psychiatry, Medical University of \u0141\u00f3d\u017a, \u0141\u00f3d\u017a, Poland<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The 34th ECNP Congress will take place on October 2-5 in Lisbon. This is the most important European scientific meeting dedicated to brain research for disease. Each year, this event attracts over 5,000 psychiatrists, neurologists and psychologists from around the world. During the 34th ECNP Congress, posters will be presented. Posters by Sylwia Janowska &#8211;<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/\" title=\"Read3 posters to be published at 34th ECNP Congress\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[30],"tags":[],"class_list":["post-22020","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>3 posters to be published at 34th ECNP Congress - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 posters to be published at 34th ECNP Congress - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"The 34th ECNP Congress will take place on October 2-5 in Lisbon. This is the most important European scientific meeting dedicated to brain research for disease. Each year, this event attracts over 5,000 psychiatrists, neurologists and psychologists from around the world. During the 34th ECNP Congress, posters will be presented. Posters by Sylwia Janowska &#8211;Read more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-14T11:39:04+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/\"},\"author\":{\"name\":\"Ma\u0142gorzata Siewierska\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"headline\":\"3 posters to be published at 34th ECNP Congress\",\"datePublished\":\"2021-09-14T11:39:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/\"},\"wordCount\":220,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/\",\"name\":\"3 posters to be published at 34th ECNP Congress - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2021-09-14T11:39:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/3-posters-to-be-published-at-34th-ecnp-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 posters to be published at 34th ECNP Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\",\"name\":\"Ma\u0142gorzata Siewierska\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3 posters to be published at 34th ECNP Congress - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/","og_locale":"en_US","og_type":"article","og_title":"3 posters to be published at 34th ECNP Congress - Celon Pharma","og_description":"The 34th ECNP Congress will take place on October 2-5 in Lisbon. This is the most important European scientific meeting dedicated to brain research for disease. Each year, this event attracts over 5,000 psychiatrists, neurologists and psychologists from around the world. During the 34th ECNP Congress, posters will be presented. Posters by Sylwia Janowska &#8211;Read more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/","og_site_name":"Celon Pharma","article_published_time":"2021-09-14T11:39:04+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/"},"author":{"name":"Ma\u0142gorzata Siewierska","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"headline":"3 posters to be published at 34th ECNP Congress","datePublished":"2021-09-14T11:39:04+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/"},"wordCount":220,"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/","url":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/","name":"3 posters to be published at 34th ECNP Congress - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2021-09-14T11:39:04+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/3-posters-to-be-published-at-34th-ecnp-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"3 posters to be published at 34th ECNP Congress"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c","name":"Ma\u0142gorzata Siewierska"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/22020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=22020"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/22020\/revisions"}],"predecessor-version":[{"id":22021,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/22020\/revisions\/22021"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=22020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=22020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=22020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}